Double-blind, placebo-controlled, multiple-ascending-dose study on the effects of ABIO-08/01, a novel anxiolytic drug, on perception and cognition, utilizing event-related potential mapping and low-resolution brain electromagnetic tomography

Human Psychopharmacology

Volumn 23, Issue 3, 2008, Pages 243-254

  Anderer, Peter ^a   Saletu, Bernd ^a   Wolzt, Michael ^a   Culic, Svetlana ^a   Assandri, Alessandro ^b   Nannipieri, Fabrizio ^c   Rosini, Sergio ^c   Saletu Zyhlarz, Gerda M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Cross SA Cross Research SA   (Switzerland)

^c Abiogen Pharma SpA   (Italy)

Author keywords

ABIO 08 01; Anxiolytic; Cognition enhancer; Low resolution brain electromagnetic tomography; Pharmaco ERP study

Indexed keywords

ABIO 08 01; ANXIOLYTIC AGENT; BTG 1640; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN MAPPING; CLINICAL TRIAL; COGNITION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG DOSE INCREASE; DRUG DOSE SEQUENCE; DRUG EFFECT; ELECTROMAGNETIC TOMOGRAPHY; EVENT RELATED POTENTIAL; EVOKED AUDITORY RESPONSE; FATIGUE; HUMAN; HUMAN EXPERIMENT; LATENT PERIOD; MALE; NORMAL HUMAN; PERCEPTION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTI-ANXIETY AGENTS; ANTICONVULSANTS; BRAIN MAPPING; COGNITION; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, AUDITORY; HUMANS; ISOXAZOLES; MALE; PERCEPTION; TOMOGRAPHY;

EID: 42549128281     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.920     Document Type: Article

References (36)

1. Abiogen Pharma SpA. 2001. Abio 08/01 - Investigator's brochure.
2. Abt K. 1991. Planning controlled clinical trials on the basis of Descriptive Data Analysis. Stat Med 10: 777-795.
3. Anderer P, Pascual-Marqui RD, Semlitsch HV, Saleta B. 1998. Differential effects of normal aging on sources of standard N1, target N1 and target P300 auditory event-related brain potentials revealed by low resolution electromagnetic tomography (LORETA). Electroencephalogr Clin Neurophysiol 108: 160-174.
4. Anderer P, Saletu B, Semlitsch HV, Pascual-Marqui RD. 2003. Non-invasive localization of P300 sources in normal aging and age-associated memory impairment. Neurobiol Aging 24: 463-479.
5. Anderer P, Saletu B, Semlitsch HV, Pascual-Marqui RD. 2002a. Perceptual and cognitive event-related potentials in neuropsychopharmacology: methodological aspects and clinical applications (pharmaco ERP topography and tomography). Methods Find Exp Clin Pharmacol 24 (Suppl C): 121-137.
6. Anderer P, Saleta B, Semlitsch HV, Pascual-Marqui RD. 2002b. Structural and energetic processes related to P300:loreta findings in depression and effects of antidepressant drugs. Methods Find Exp Clin Pharmacol 24 (Suppl D): 85-91.
7. Anderer P, Semlitsch HV, Eberstaller M, Saletu B, Pfundner P. 1999. A robust and valid artifact minimization and identification procedure for 'cognitive' event-related brain potentials. Med Biol Eng Comput 27 (Suppl. 2): 486-487.
8. Anderer P, Semlitsch HV, Saletu B, Barbanoj MJ. 1992. Artifact processing in topographic mapping of EEG in neuropsychopharmacology. Psychiat Res 45: 79-93.
9. Anderer P, Saleta B, Saletu-Zyhlarz G, et al. 2004. Brain regions activated during an auditory discrimination task in insomniac postmenopausal patients before and after hormone replacement therapy: low-resolution brain electromagnetic tomography applied to event-related potentials. Neuropsychobiology 49: 134-153.
10. Baillet S, Mosher JC, Leahy RM. 2001. Electromagnetic brain mapping. IEEE Signal Proc Mag 18: 14-30.
11. Cross EM, Chaffin WW. 1982. Use of the binomial theorem in interpreting results of multiple tests of significance. Educ Psychol Meas 42: 25-34.
12. Ferber G, Abt K, Fichte K, Luthringer R. 1999. IPEG guideline on statistical design and analysis for pharmacodynamic trials. Neuropsychobiology 39: 92-100.
13. Halgren E, Matinkovic K, Chauvel P. 1998. Generators of the late cognitive potentials in auditory and visual oddball tasks. Electroencephalogr Clin Neurophysiol 106: 156-164.
14. Kok A. 1997. Event-related-potential (ERP) reflections of mental resources: a review and synthesis. Biol Psychol 45: 19-56.
15. Lancester JL, Rainey LH, Summerlin JL, et al. 1997. Automated labeling of the human brain - a preliminary report on the development and evaluation of a forward transform method. Hum Brain Mapp 5: 238-242.
16. Lorist MM, Snel J, Mulder G, Kok A. 1995. Aging, caffeine, and information processing: an event-related potential analysis. Electroencephalogr Clin Neurophysiol 96: 453-467.
17. Näätänen R. 1989. Implications of event-related potentials data for psychological theories of attention. In Event-Related Potentials Investigations of Cognition, Renault M, Kutas M, Coles MGH, Gailland AGM (eds). North Holland: Amsterdam; 117-164.
18. Pascual-Marqui RD, Esslen M, Kochi K, Lehmann D. 2002. Functional imaging with low resolution brain electromagnetic tomography (LORETA): review, new comparisons, and new validation. Jpn J Clin Neurophysiol 30: 81-94.
19. Pascual-Marqui RD, Lehmann D, Koenig T, et al. 1999. Low resolution brain electromagnetic tomography (LORETA) functional imaging in acute, neuroleptic-naïve, first-episode, productive schizophrenia. Psychiatry Res Neuroimaging 90: 169-179.
20. Pascual-Marqui RD, Michel CM, Lehmann D. 1994. Low resolution electromagnetic tomography: a new method for localizing electrical activity in the brain. Int J Psychophysiol 18: 49-65.
21. Pascual-Marqui RD. 1994. Low resolution electromagnetic tomography. Brain Topogr 7: 180.
22. Picton TW, Hillyard SA. 1988. Endogenous event-related potentials. In Handbook of Electroencephalography and Clinical Neurophysiology. Human Event-Related Potentials, Picton TW (ed.). Elsevier: Amsterdam; 361-426.
23. Polich J. 1998. P300 clinical utility and control of variability. J Clin Neurophysiol 15: 14-33.
24. Saletu B. 1974. Classification of psychotropic drugs based on human evoked potentials. In Psychotropic Drugs and the Human EEG, Itil TM (ed.). Karger: New York-Basel; 258-285.
25. Saletu B. 1977a. Cerebral evoked potentials in psychopharmacology. In Auditory Evoked Potentials in Man. Psychopharmacology of EPs, Desmedt JE (ed). Karger: Basel; 175-207.
26. Saletu B. 1977b. The evoked potentials in pharmacopsychiatry. Neuropsychobiology 3: 75-104.
27. Semlitsch HV, Anderer P, Saletu B, Resch F, Presslich O, Schuster P. 1989. Psychophysiological research in psychiatry and neuropharmacology. I. Methodological aspects of the Viennese Psychophysiological Test-System (VPTS). Meth Final Exp Clin Pharmacol 11: 25-41.
28. Semlitsch HV, Anderer P, Saletu B, Binder GA, Decker KA. 1993. Acute effects of the novel antidepressant venlafaxine on cognitive event-related potentials (P300), eye blink rate and mood in young healthy subjects. Int Clin Psychopharmacol 8: 155-166.
29. Semlitsch HV, Anderer P, Saletu B, Binder GA, Decker KA. 1995a. Cognitive psychophysiology in nootropic drug research: effects of ginkgo biloba on event-related potentials (P300) in age-associated memory impairment. Pharmacopsychiatry 28: 134-142.
30. Semlitsch HV, Anderer P, Saletu B. 1995b. Acute effects of the anxiolytics suriclone and alprazolam on cognitive information processing utilizing topographic mapping of event-related brain potentials (P300) in healthy subjects. Eur J Clin Pharmacol 49: 183-191.
31. Semlitsch HV, Anderer P, Schuster P, Presslich O. 1986. A solution for reliable and valid reduction of ocular artifacts applied to the P300 ERP. Psychophysiology 23: 695-703.
32. Shagass C, Straumanis JJ. 1978. Drugs and human sensory evoked potentials. In Psychopharmacology: A Generation of Progress, Lipton A, DiMascio A, Killam KF (eds). Raven Press: New York; 699-709.
33. Squires NK, Squires KC, Hillyard SA. 1975. Two varieties of long-latency positive waves evoked by unpredictable auditory stimuli in man. Electroencephalogr Clin Neurophysiol 38: 387-401.
34. Strik WK, Fallgatter AJ, Brandeis D, Pascual-Marqui RD. 1998. Three-dimensional tomography of event-related potentials during response inhibition: evidence for phasic frontal lobe activation. Electroencephalogr Clin Neurophysiol 108: 406-413.
35. Talairach J, Tournoux P. 1988. Co-Planar Stereotaxic Atlas of the Human Brain. Thieme: Stuttgart.
36. Winterer G, Mulert C, Mientus S, et al. 2001. P300 and LORETA: comparison of normal subjects and schizophrenic patients. Brain Topogr 13: 299-313.